Skip to main content
. 2020 Nov 10;2020:2180708. doi: 10.1155/2020/2180708

Table 2.

Comparison of anti-Tyro3 antibody according to disease manifestations in 70 new-onset and treatment-naïve SLE patients.

Anti-Tyro3 IgG (OD 450) p value
Photosensitivity (+), n = 10 0.645 ± 0.185 0.185
(-), n = 60 0.578 ± 0.177
Raynaud's phenomenon (+), n = 13 0.594 ± 0.187 0.898
(-), n = 57 0.586 ± 0.178
Fever (+), n = 32 0.618 ± 0.228 0.402
(-), n = 38 0.562 ± 0.121
Serositis (+), n = 16 0.606 ± 0.153 0.243
(-), n = 54 0.582 ± 0.187
Oral ulcer (+), n = 16 0.698 ± 0.264 0.035
(-), n = 54 0.555 ± 0.131
Rash (+), n = 36 0.605 ± 0.214 0.953
(-), n = 34 0.569 ± 0.132
Alopecia (+), n = 16 0.599 ± 0.157 0.796
(-), n = 54 0.584 ± 0.186
Arthritis (+), n = 42 0.607 ± 0.178 0.148
(-), n = 28 0.558 ± 0.179
Vasculitis (+), n = 5 0.634 ± 0.166 0.367
(-), n = 65 0.584 ± 0.180

Note: anti-Tyro3 IgG (OD 450) are shown as mean ± SD, and differences between two groups were analyzed using the independent samples t-test for normal data and the Mann-Whitney U test for nonnormal data. SLE: systemic lupus erythematosus. p < 0.05.